IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sinovac Biotech LTD (SVA)

CUSIP: P8696W104 | 146 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ASaif Partners IV L.P.10,780,82015.0%New 5%+ stakeDec 15, 2025No 13F filer matched
13D/ASaif Partners IV L.P.10,780,820
15.0% of class · Dec 15, 2025New 5%+ stake
No 13F filer matched

Institutional Holders — Q3 2026

Neumann Advisory Hong Kong Ltd315,586
0.0% of portfolio›$2.0K
IFP Advisors, Inc200
0.0% of portfolio›$0
TD Private Client Wealth LLC0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Neumann Advisory Hong Kong Ltd
315,586$2.0K0.0%CoreVery LowCentral, South Korea2026-10-08
IFP Advisors, Inc
200$00.0%GrowthLowTampa, FL2026-10-16
TD Private Client Wealth LLC
0$00.0%ETFLowNew York, NY2026-10-28